G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,371 | -7.1% | 26,655 | 0.0% | 0.00% | – |
| Q1 2023 | $71,435 | -93.4% | 26,655 | -86.7% | 0.00% | -100.0% |
| Q4 2022 | $1,086,000 | +1623.8% | 200,000 | +1480.3% | 0.01% | +400.0% |
| Q2 2022 | $63,000 | -98.9% | 12,656 | -88.5% | 0.00% | -98.2% |
| Q3 2018 | $5,770,000 | +357.9% | 110,348 | +224.4% | 0.06% | +460.0% |
| Q1 2018 | $1,260,000 | -74.7% | 34,016 | -83.0% | 0.01% | -54.5% |
| Q3 2017 | $4,978,000 | +42.7% | 200,000 | 0.0% | 0.02% | +15.8% |
| Q2 2017 | $3,488,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |